Your email has been successfully added to our mailing list.

×
-0.00857142857142858 -0.0074285714285714 -0.0142857142857143 0.0285714285714286 0.0142857142857143 0.0142857142857143 0.000142857142857127 0.0428571428571429
Stock impact report

AZTR: First ATR-12 Patient Screened [Yahoo! Finance]

Azitra Inc (AZTR) 
Company Research Source: Yahoo! Finance
Azitra, Inc. (NYSE:AZTR) reported second quarter results following a $10 million raise which enabled the company to begin enrolling its ATR-12 Phase Ib trial for Netherton Syndrome. Just days after the 2Q:24 report, the company announced that the first patient for the ATR-12 trial had been screened and scheduled to initiate treatment before the end of August. A few days later, the company announced that its ATR-04 investigational new drug (IND) application for EGFRi-related skin rash was cleared by the FDA. A Phase I/II study is planned for year-end 2024. Year to date, Azitra has been granted several patents for its ATR-12 and ATR-04 candidates, presented at numerous conferences and strengthened its balance sheet in order to advance its engineered bacterial candidates in dermatology. We recently initiated on Azitra providing a review of Netherton Syndrome, the competitive environment and factors impacting and contributing to our valuation of the enterprise. Below we provide a summa Show less Read more
Impact Snapshot
Event Time:
AZTR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AZTR alerts
Opt-in for
AZTR alerts

from News Quantified
Opt-in for
AZTR alerts

from News Quantified